Role of cytochrome P450s in insecticide resistance: impact on the control of mosquito-borne diseases and use of insecticides on Earth.
David JP, Ismail HM, Chandor-Proust A, Paine MJ. · 2013
Read Role of cytochrome P450s in insecticide resistance: impact on the control of mosquito-borne diseases and use of insecticides on Earth. by David JP, Ismail HM, Chandor-Proust A, Paine MJ. (2013) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3538419.txt.
Introduction
Mosquitoes out-evolve insecticides partly through detox enzymes, and Jean-Philippe David, Hanafy Mahmoud Ismail, Alexia Chandor-Proust, and Mark John Ingraham Paine review the cytochrome P450 side of that arms race in 2013. Malaria and dengue control still lean on chemical insecticides, and resistance keeps eroding them.
Mosquitoes carry over a hundred P450 genes. New genomic and functional tools are finally pinning down which enzymes metabolize insecticides, and how the same enzymes answer pollutants. Knowing the culprits enables diagnostics that spot resistance early and insecticides designed to dodge or exploit the enzymes. The authors frame P450 profiling as a way to protect both disease control and the environment.
Catalog record
| CREATOR | David JP, Ismail HM, Chandor-Proust A, Paine MJ. |
|---|---|
| YEAR | 2013 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 68 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Role of cytochrome P450s in insecticide resistance: impact on the control of mosquito-borne diseases and use of insecticides on Earth By Jean-Philippe David, Hanafy Mahmoud Ismail, Alexia Chandor-Proust, Mark John Ingraham Paine Published in: Philosophical Transactions of the Royal Society B: Biological Sciences DOI: 10.1098/rstb.2012.0429 ABSTRACT Abstract The fight against diseases spread by mosquitoes and other insects has enormous environmental, economic and social consequences. Chemical insecticides remain the first line of defence but the control of diseases, especially malaria and dengue fever, is being increasingly undermined by insecticide resistance. Mosquitoes have a large repertoire of P450s (over 100 genes). By pinpointing the key enzymes associated with insecticide resistance we can begin to develop new tools to aid the implementation of control interventions and reduce their environmental impact on Earth. Recent technological advances are helping us to build a functional profile of the P450 determinants of insecticide metabolic resistance in mosquitoes. Alongside, the cross-responses of mosquito P450s to insecticides and pollutants are also being investigated. Such research will provide the means to produce diagnostic tools for early detection of P450s linked to resistance. It will also enable the design of new insecticides with optimized efficacy in different environments. Keywords: mosquito, malaria, dengue, pyrethroids, oxidases, detoxification INTRODUCTION Insect vectors are responsible for almost 20 per cent of all infectious diseases affecting people in developing countries [1]. This review focuses on mosquitoes as they are the commonest disease carriers for a host of parasites such as bacteria and viruses in man. Three species that are particularly important to man are Anopheles gambiae, which transmits malaria, Aedes aegypti, which transmits dengue and other viruses, and Culex quinquifasciatus, a vector for West Nile virus and other viral encephalitides. Their medical importance is reflected by the fact that they were among the first wave of genomes to be sequenced, An. gambiae in 2002 [2], Ae. aegypti in 2007 [3] and C. quinquifasciatus in 2010 [4]. This has revealed an extensive repertoire of P450s (more than 100) allowing the development of new tools for investigating the functional role of mosquito P450s and their relationships with insecticide metabolism. The fight against diseases spread by mosquitoes has enormous environmental, economic and social consequences. Chemical insecticides remain the first line of defence but the control of disease is being undermined by resistance. P450s have been fundamental to the successful adaptation of insects to diverse habitats [5,6], thus the highly evolved P450 repertoire of mosquitoes provides excellent protection against insecticides and other xenobiotics, a subject that has been well reviewed [5,7,8]. However, there is limited knowledge about which P450s are responsible for insecticide resistance in mosquitoes. Furthermore, given their primary role in defence against plant and environmental toxins, it is unclear to what extent pollutants and other xenobiotics might influence the adaptation of the mosquitoes' P450 repertoire to its chemical environment and modulate insecticide resistance mechanisms. Filling-in these knowledge gaps will have important impact on the use of insecticides to improve efficiency and resistance management strategies as discussed in this review. DISEASES SPREAD BY MOSQUITOES Mosquitoes transmit many diseases including malaria, dengue fever, Japanese encephalitis virus, West Nile virus, yellow fever virus and filariasis. Of these, malaria transmitted primarily by An. gambiae, dengue transmitted by Ae. aegypti and lymphatic filariasis transmitted by C. quinquifasciatus are the most devastating problems in terms of the global number of people affected. Approximately half of the world's population are at risk of malaria, with 225 million cases being recorded in 2009 [9]. Dengue fever, a flavivirus transmitted by Aedes mosquitoes (mainly Ae. aegypti and Ae. albopictus), is an increasingly serious public health problem in over 100 countries with some 2.5 billion people at risk [10]. Culex quinquefasciatus is a major biting nuisance in the urban tropics, and is a vector for West Nile virus in addition to lymphatic filariasis, which affects 120 million people worldwide, and can lead to genital damage and elephantiasis. Apart from the obvious health issues, the economic and environmental costs are high. Such diseases have detrimental effects on fertility, population growth, saving and investment, worker productivity and absenteeism, premature mortality and medical costs. Indeed, it has been estimated that every year malaria causes a gross domestic product (GDP) loss of $US 12 billion to Africa [11]. Thus, countries with high malaria transmission have had historically lower economic growth than countries without malaria. INSECTICIDES Given the obvious environmental impact of chemicals, why, in the twenty-first century, are we still using insecticides? In short, because for many vector-borne diseases they remain the cheapest, most effective method available. In the case of dengue, insecticides are the only realistic option for disease control as there are no clinically approved vaccines or antiviral therapies available [12]. In the case of malaria, drugs are available but there are problems of drug resistance and affordability [13–15]. Likewise, there are no clinically approved vaccines, although recent trials of a candidate malaria vaccine RTSS/AS01 are showing enough promise (approx. 50% protection) to suggest that vaccination will be a viable option in the foreseeable future [16]. Thus, targeting the vector remains the most effective option to significantly reduce disease transmission. Environmental liabilities have, however, encouraged the development of natural alternatives with less side-effects. These include bacterial toxins from Bacillus thuringiensis var. israelensis, which are effective against mosquito larvae [17,18], and entomopathogenic fungi such as Beauveria bassiana and Metarhizium anisopliae, which are effective in killing adult mosquitoes [19–21]. There is also an escalating use of synthetic insect hormones to disrupt an insect's vital processes, such as growth or metamorphosis; and synthetic pheromones, powerful insect sex attractants, to sabotage pest reproduction and lure pests into traps. Finally, there is growing interest in the release of sterilized male insects to compete with fertile males for mates, diminishing the population of the next generation. The first open-field trial of transgenic Ae. aegypti in the Cayman Islands indicates that large-scale releases of mosquitoes to fight infectious diseases is feasible [22–24]. However, the high cost associated with this technique and the acceptance of genetically modified organism usage by stakeholders and populations may limit this approach. Common chemical interventions include insecticide treated nets (ITNs), indoor residual spraying (IRS) and space spraying or fogging that target the adult stage (epidemiologically the most important life stage) [25]. Choice of application is largely dependent on mosquito behaviour. For indoor night biters such as An. gambiae and C. quinquifasciatus, bednets and IRS are effective. However, bednets and IRS have limited value against Ae. aegypti and Ae. albopictus as they are outdoor daytime biters; fogging and larviciding are generally used, which are less effective and logistically challenging. At present there are only four approved classes of insecticides (table 1) with only two modes of action, inhibition of the sodium channels (pyrethroids and DDT) or acetylcholine esterase (organophosphates and carbamates) (figure 1). This limited number plus the fact that no new insecticides have been approved for vector control by WHO in the last 30 years has greatly increased the threat of resistance and the sustainability of chemical insecticides for vector control. Pyrethroid insecticides are particularly vulnerable as they are the only insecticide class recommended for ITNs [27,28]. Between 2008 and 2010 more than 254 million ITNs have been delivered to malaria endemic countries in